Cargando…

MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer

Two common mutations, 677 C→T and a1298 A→C, in the methylenetetrahydrofolate reductase gene (MTHFR) reduce the activity of MTHFR and folate metabolism. Familial aggregation in a variable but significant proportion of gastric cancer (GC) cases suggests the importance of genetic predisposition in det...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Re, Valli, Cannizzaro, R., Canzonieri, V., Cecchin, E., Caggiari, L., De Mattia, E., Pratesi, C., De Paoli, P., Toffoli, G.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803747/ https://www.ncbi.nlm.nih.gov/pubmed/20237899 http://dx.doi.org/10.1007/s13277-009-0004-1

Ejemplares similares

Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
por: Repetto, Ombretta, et al.
Publicado: (2014)

Identification and Characterization of CDH1 Germline Variants in Sporadic Gastric Cancer Patients and in Individuals at Risk of Gastric Cancer
por: Garziera, Marica, et al.
Publicado: (2013)

Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients
por: Corona, Giuseppe, et al.
Publicado: (2018)

Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer
por: De Re, Valli, et al.
Publicado: (2017)

Differential Helicobacter pylori Plasticity in the Gastric Niche of Subjects at Increased Gastric Cancer Risk
por: Casarotto, Mariateresa, et al.
Publicado: (2019)

Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
por: Re, Valli De, et al.
Publicado: (2021)

Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2016)

Family’s History Based on the CDH1 Germline Variant (c.360delG) and a Suspected Hereditary Gastric Cancer Form
por: Caggiari, Laura, et al.
Publicado: (2020)

Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2019)

Overview of Epstein–Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options
por: Re, Valli De, et al.
Publicado: (2020)

Immunotherapy for Gastric Cancer: Time for a Personalized Approach?
por: Dolcetti, Riccardo, et al.
Publicado: (2018)

A DSC Test for the Early Detection of Neoplastic Gastric Lesions in a Medium-Risk Gastric Cancer Area
por: De Re, Valli, et al.
Publicado: (2023)

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype
por: Caggiari, Laura, et al.
Publicado: (2017)

Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis
por: Fornasarig, Mara, et al.
Publicado: (2018)

Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors
por: Magris, Raffaella, et al.
Publicado: (2020)

Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer
por: De Re, Valli, et al.
Publicado: (2020)

Proposed Molecular and miRNA Classification of Gastric Cancer
por: Alessandrini, Lara, et al.
Publicado: (2018)

Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
por: Repetto, Ombretta, et al.
Publicado: (2017)

HER2–CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients’ Survival in HER2-Positive Metastatic Gastric Adenocarcinoma
por: De Re, Valli, et al.
Publicado: (2022)

Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma
por: Repetto, Ombretta, et al.
Publicado: (2018)

Endomicroscopy and Cancer: A New Approach to the Visualization of Neoangiogenesis
por: Cannizzaro, Renato, et al.
Publicado: (2012)

Molecular Features Distinguish Gastric Cancer Subtypes
por: De Re, Valli
Publicado: (2018)

Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy
por: De Re, Valli, et al.
Publicado: (2014)

Two-dimensional gel proteome reference map of human small intestine
por: Simula, Maria Paola, et al.
Publicado: (2009)

Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
por: Dreussi, Eva, et al.
Publicado: (2016)

Association of HLA-G 3′UTR Polymorphisms with Response to First-Line FOLFIRI Treatment in Metastatic Colorectal Cancer
por: Scarabel, Lucia, et al.
Publicado: (2022)

Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer
por: Repetto, Ombretta, et al.
Publicado: (2021)

A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach
por: Caggiari, Laura, et al.
Publicado: (2017)

A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
por: Dalle Fratte, Chiara, et al.
Publicado: (2022)

MTHFR C677T and A1298C Polymorphisms in Breast Cancer, Gliomas and Gastric Cancer: A Review
por: Petrone, Igor, et al.
Publicado: (2021)

Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer
por: Ebert, M P A, et al.
Publicado: (2000)

Probe-based confocal laser endomicroscopy for in vivo evaluation of the tumor vasculature in gastric and rectal carcinomas
por: Spessotto, Paola, et al.
Publicado: (2017)

pCLE highlights distinctive vascular patterns in early gastric cancer and in gastric diseases with high risk of malignant complications
por: Fornasarig, Mara, et al.
Publicado: (2021)

Increased expression of survivin in gastric cancer patients and in first degree relatives
por: Yu, J, et al.
Publicado: (2002)

Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients
por: Dreussi, Eva, et al.
Publicado: (2016)

MTHFR polymorphisms and breast cancer risk
por: Hosseini, Mojgan, et al.
Publicado: (2011)

A retrospective comparative exploratory study on two Methylentetrahydrofolate Reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients
por: Blank, Susanne, et al.
Publicado: (2014)

Preferences of first-degree relatives of gastric cancer patients for gastric cancer screening: a discrete choice experiment
por: Li, Hui-qin, et al.
Publicado: (2021)

Association of MTHFR gene polymorphisms with breast cancer survival
por: Martin, Damali N, et al.
Publicado: (2006)

SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy
por: De Mattia, Elena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oikuiv8e5ko7pbhl2og0i58l90